A new development of indirect gating case in the differential decay curve method used for lifetime measurement has been introduced.The gate region was extended from partial shifted peak to both shifted and unshifted c...A new development of indirect gating case in the differential decay curve method used for lifetime measurement has been introduced.The gate region was extended from partial shifted peak to both shifted and unshifted components.The statistics of flight and stop peaks in gating spectra was improved obviously.The reliability of this change has been tested by reanalysing the lifetime of 2^+ state in^(134) Ce.The result of 32.2(33) ps was fit well with the previous published values within the experimental uncertainty.The developed method was also used to analyse the lifetime of 2_1^+ state in^(138) Nd.展开更多
Lifetimes of the 2_(1)^(+),4_(1)^(+),7_(2)^(-),10_(2)^(+),12_(2)^(+),and 14_(1)^(+) states in 138 Nd populated via the 123 Sb(19 F,4n)138 Nd fusion–evaporation reaction were measured with the recoil distance Doppler ...Lifetimes of the 2_(1)^(+),4_(1)^(+),7_(2)^(-),10_(2)^(+),12_(2)^(+),and 14_(1)^(+) states in 138 Nd populated via the 123 Sb(19 F,4n)138 Nd fusion–evaporation reaction were measured with the recoil distance Doppler shift technique in combination with the differential decay curve method.The B(E2;2_(1)^(+)→0_(1)^(+))value fit well with the systematic trend in the Nd isotope chain and Grodzins rule,which proved that 138Nd is a transitional nucleus.展开更多
Background： Coronary intervention therapy is the main treatment for uremic patients with coronary heart disease. The studies on whether dialysis reduces the efficacy of dual antiplatelet drugs are limited. The aim of...Background： Coronary intervention therapy is the main treatment for uremic patients with coronary heart disease. The studies on whether dialysis reduces the efficacy of dual antiplatelet drugs are limited. The aim of this study was to examine the effect of dialysis on antiplatelet drugs in uremic patients with coronary heart disease. Methods： This study included 26 uremic patients who had undergone percutaneous coronary intervention in China-Japan Friendship Hospital from November 2015 to May 2017. We examined their thromboelastography results before and after hemodialysis. Self-paired t-tests were employed to analyze changes in the inhibition rate of platelet aggregation. Results： The mean inhibition rates of arachidonic acid-induced platelet aggregation before and after hemodialysis were 82.56 ± 2.79% and 86.42±3.32%, respectively （t =-1.278, P = 0.213）. The mean inhibition rates of adenosine diphosphate-induced platelet aggregation before and after hemodialysis were 67.87± 5.10% and 61.9± 5.90%, respectively （t = 1.425, P = 0.167）. There was no significant difference in the inhibition rates ofplatelet aggregation before or after hemodialysis. These results also applied to patients with different sensitivity to aspirin and clopidogrel. Conclusion： Dialysis did not affect the antiplatelet effects of aspirin and clopidogrel in uremic patients with coronary heart disease.展开更多
基金supported by the National Natural Science Foundation of China(No.11475072,11375267,11305269,11405274,11405072,11205069,11775307,11375266,11575118 and 11605114)the National Natural Science Foundation of Guangdong,China(No.2016A030310042)+1 种基金the National Key Research and Development Program of Chinathe National Key Scientific Instrument and Equipment Development Projects,China(No.2017YFF0106501)
文摘A new development of indirect gating case in the differential decay curve method used for lifetime measurement has been introduced.The gate region was extended from partial shifted peak to both shifted and unshifted components.The statistics of flight and stop peaks in gating spectra was improved obviously.The reliability of this change has been tested by reanalysing the lifetime of 2^+ state in^(134) Ce.The result of 32.2(33) ps was fit well with the previous published values within the experimental uncertainty.The developed method was also used to analyse the lifetime of 2_1^+ state in^(138) Nd.
基金This work was supported by the National Natural Science Foundation of China(Nos.U1932209,11975315,U1867210,and 11905134)the Leading Innovation Project(Nos.LC192209000701 and LC202309000201)+1 种基金the Continuous Basic Scientific Research Project(Nos.BJ20002501 and WDJC-2019-13)the China National Nuclear Corporation(No.FA18000201).
文摘Lifetimes of the 2_(1)^(+),4_(1)^(+),7_(2)^(-),10_(2)^(+),12_(2)^(+),and 14_(1)^(+) states in 138 Nd populated via the 123 Sb(19 F,4n)138 Nd fusion–evaporation reaction were measured with the recoil distance Doppler shift technique in combination with the differential decay curve method.The B(E2;2_(1)^(+)→0_(1)^(+))value fit well with the systematic trend in the Nd isotope chain and Grodzins rule,which proved that 138Nd is a transitional nucleus.
基金This study was supported by the grants from the National Natural Science Foundation of China （No. 91639110） and National Natural Science Foundation of China （No. 81500326）.
文摘Background： Coronary intervention therapy is the main treatment for uremic patients with coronary heart disease. The studies on whether dialysis reduces the efficacy of dual antiplatelet drugs are limited. The aim of this study was to examine the effect of dialysis on antiplatelet drugs in uremic patients with coronary heart disease. Methods： This study included 26 uremic patients who had undergone percutaneous coronary intervention in China-Japan Friendship Hospital from November 2015 to May 2017. We examined their thromboelastography results before and after hemodialysis. Self-paired t-tests were employed to analyze changes in the inhibition rate of platelet aggregation. Results： The mean inhibition rates of arachidonic acid-induced platelet aggregation before and after hemodialysis were 82.56 ± 2.79% and 86.42±3.32%, respectively （t =-1.278, P = 0.213）. The mean inhibition rates of adenosine diphosphate-induced platelet aggregation before and after hemodialysis were 67.87± 5.10% and 61.9± 5.90%, respectively （t = 1.425, P = 0.167）. There was no significant difference in the inhibition rates ofplatelet aggregation before or after hemodialysis. These results also applied to patients with different sensitivity to aspirin and clopidogrel. Conclusion： Dialysis did not affect the antiplatelet effects of aspirin and clopidogrel in uremic patients with coronary heart disease.
